+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Keloids Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials

  • PDF Icon


  • 70 Pages
  • November 2021
  • Region: Global
  • VPA Research
  • ID: 5463771
UP TO OFF until Jan 05th 2023
Keloids pipeline drugs and companies, 2021- Phase, Mechanism of Action, Route, Licensing/collaboration, pre-clinical and clinical trials

The global comprehensive report on “Keloids pipeline drugs and companies” presents key-decision makers with critical insights into Keloids pipeline data. It provides complete analysis on pipeline drugs detailing Phases, route of administration, mechanism of action, licensing and collaborations, clinical trial details including pre-clinical phase and clinical trials.

Keloids pipeline Drug Snapshot, 2021

The Keloids pipeline study analyzes and monitors the development landscape with the current status of each of the pipeline drugs under development for Keloids. In addition to recent status, overview of drugs is included in the study. Wide range of Keloids drug related details including of company, indication, country, current status, drug alternative names, originator, orphan drug status, fast track details and others are provided.

Keloids drug development pipeline by phase

The Keloids pipeline study monitors the progress of new drug programs and provides analysis of phases, covering drugs from discovery to launch including discovery stage, preclinical, phase 1, phase 2, phase 3, pre-registration and other phases. The drug development stage for all Keloids pipeline candidates is provided in the report enables you to understand timetable developments in Keloids therapeutic area.

Keloids pipeline drug Technology, Licensing and Collaboration Details

Details of technologies used for development of Keloids pipeline candidates, licensing and collaboration agreements, partnership and other announcements, regulatory approval and other details are included in the Keloids research study. Companies looking to partner with other players are also detailed in the report.

Keloids- mechanism of action of pipeline candidates

Keloids pipeline guide details the mechanism of action of each of the drug candidate under development. Further, leading types of mechanism of action (MoA) targeted by different Keloids companies are identified to support decision makers target the most potential drugs under development.

Further, route of administration including oral, topical, sub-cutaneous, IV, ophthalmic and others are provided to assist researchers to understand most sought and least sought route of Keloids drug administration.

Keloids Drugs- Preclinical and Clinical Trials

This chapter in Keloids preclinical and clinical trials assists in gaining clear understanding of the timetable developments in Keloids product area. Preclinical and clinical trial details of pipeline candidates for Keloids are detailed in the report. Details including participants, duration, companies, locations and others are provided for the trials.

Keloids companies and Profiles

Companies developing Keloids pipeline products are analyzed in the industry report, presenting details of business overview, location, and year of establishment, contacts, key employees, and a brief business profile.

Keloids Market Developments

The report presents the recent news and developments in the Keloids pipeline industry. Progress of candidates, mergers, acquisitions, asset transactions, licensing, collaborations, partnership and joint ventures, regulatory approvals, marketing and other relevant news and deals are discussed in the report.

Reasons to Buy

  • Make better-informed decisions based on the current status of each of the pipeline drug candidate
  • Identify new business opportunities by evaluating the progress of the Keloids R&D pipeline
  • Analyze the market and research segments based on a comprehensive analysis of Keloids pipeline drugs and clinical trials
  • Identify Keloids drug pipeline trends based on consistently delivered hands on pipeline and clinical trials information
  • Gain clear understanding of the Keloids drugs through our expert coverage and in-depth analysis of drugs, companies and market trends
  • Check the Keloids pipeline progress of target companies and key strategies of leading players
  • Gain real-time insights into the global Keloids pipeline news, developments and insights

Scope of the Report

  • Disease overview including Keloids symptoms, widely used treatment options, companies and other details are included
  • Keloids Pipeline Summary including the dominant phase type, number of drug candidates progressing to advanced phases, early stage pipeline candidates, leading companies, dominant route of mechanism and route of administration and other details are provided.
  • Keloids pipeline drug count by phase, company and mechanism of action
  • Keloids companies investing R&D resources in pipeline
  • Dominant Mechanism of Action
  • Most researched route of administration
  • For each pipeline candidate, drug, originator, co-developers, other companies, special status, phase, synonym, current status and other details are included
  • Clinical trial information for each Keloids pipeline candidate are provided including preclinical, phase 1, phase 2 and phase 3 details
  • Keloids companies including their business snapshot, business description and Keloids pipelines are included.
  • Recent Keloids market developments, pipeline news and deals are provided

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Keloids Disease overview
2.2 Companies investing in Keloids industry
3 Keloids Pipeline Snapshot, 2021
3.1 Keloids Pipeline Drugs- Dominant phase type
3.2 Keloids pipeline Drugs- Leading Mechanism of Action
3.3 Keloids Pipeline Drugs- Widely researched Route of Administration
3.4 Keloids Pipeline- New Molecular Entity
3.5 Keloids pipeline- Companies, Universities and Institutes
4. Keloids Drug Profiles
4.1 Current Status of Keloids Drug Candidates, 2021
4.2 Keloids Drugs in Development- Originator/Licensor
4.3 Keloids Drugs in Development- Route of Administration
4.4 Keloids Drugs in Development- New Molecular Entity (NME)
5. Keloids Clinical Trials
5.1 Preclinical Trial details
5.2 Phase 1 Clinical Trial Details
5.3 Phase 2 Clinical Trial Details
5.4 Phase 3 Clinical Trial Details
6. Keloids Companies and Universities
6.1 Leading Keloids companies researching in drug development
6.2 Leading Keloids Universities/Institutes investing in drug development
7. Keloids News and Deals
7.1 Recent Keloids Market Developments
7.2 Pipeline Drug News Updates
7.3 Pipeline Company updates
8. Appendix
8.1 Sources and Research Methodology
8.2 Online Database
8.3 Primary and Secondary Methodology
8.4 Customization options
8.5 Contact